Medications

Few alarms over cases of drug-resistant COVID

As the latest coronavirus variant upends expectations about the pandemic's coming months, drug manufacturers are working to expand treatment options to fight those stricken with severe disease. Even as new pills from Pfizer ...

Biomedical technology

Mapping complex variability onto intricate virtual models

Anybody who has ever seen a picture of a brain knows that it's not a simple smooth oval; it's more like a tangle of fat worms. But when researchers seek to predict and understand its physical and electrical behavior, they ...

Cardiology

Sodium in unexpected places

A patient with diabetes and heart disease told me he hardly uses salt. "I do buy more convenience foods since my wife died, though," he continued. That's an issue, according to new guidance to food manufacturers from the ...

Vaccination

Oxford vaccine reaches 2-billion-dose milestone

Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply, University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented ...

Vaccination

Franco-Austrian firm Valneva wins EU COVID jab deal

Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.

Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

Medications

Powerful new antivirals for COVID are coming

(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.

page 9 from 40